Antitumour combinations containing a vegf inhibiting agent and irinotecan
作者： Patricia Vrignaud , Marie-Christine Bissery , Marielle Chiron-Blondel , Pascale Lejeune
DOI:
关键词: Medicine 、 VEGF receptors 、 Irinotecan 、 Pharmacology
摘要: Antitumour combinations of VEGF inhibitors with Irinotecan therapeutic use in the treatment neoplastic diseases.
lens.org 参考文章(8)
Jesse M. Cedarbaum, Marielle Chiron-Blondel, Jocelyn Holash, Marie-Christine Bissery, Patricia Vrignaud, Eric Furfine, Antitumor combinations containing a VEGF-inhibiting agent and 5FU or a derivative thereof ,(2009)
George D. Yancopoulos, Limin Hu, Robert Jaffe, Jocelyn Holash, Method of treating cancer with a VEGF antagonist and an anti-proliferative agent ,(2004)
Kenji Yokoi, Premal H. Thaker, Sertac Yazici, Robert R. Rebhun, Do-Hyun Nam, Junqin He, Sun-Jin Kim, James L. Abbruzzese, Stanley R. Hamilton, Isaiah J. Fidler, Dual Inhibition of Epidermal Growth Factor Receptor and Vascular Endothelial Growth Factor Receptor Phosphorylation by AEE788 Reduces Growth and Metastasis of Human Colon Carcinoma in an Orthotopic Nude Mouse Model Cancer Research. ,vol. 65, pp. 3716- 3725 ,(2005) , 10.1158/0008-5472.CAN-04-3700
U Vanhoefer, P Rougier, M Borner, A Muñoz, J.-L Van Laethem, A Sobrero, Irinotecan in combination with new agents Ejc Supplements. ,vol. 2, pp. 14- 20 ,(2004) , 10.1016/J.EJCSUP.2004.04.010
Yasemin D Yazici, Seungwon Kim, Samar A Jasser, Zhuoying Wang, Kenny B Carter Jr, Corazan D Bucana, Jeffrey N Myers, None, Antivascular therapy of oral tongue squamous cell carcinoma with PTK787 Laryngoscope. ,vol. 115, pp. 2249- 2255 ,(2005) , 10.1097/01.MLG.0000183861.53765.77
Paulo M. Hoff, Robert A. Wolff, Karla Bogaard, Sherry Waldrum, James L. Abbruzzese, A phase I study of escalating doses of the tyrosine kinase inhibitor semaxanib (SU5416) in combination with irinotecan in patients with advanced colorectal carcinoma Japanese Journal of Clinical Oncology. ,vol. 36, pp. 100- 103 ,(2006) , 10.1093/JJCO/HYI229
Susan Jones-Bolin, Hugh Zhao, Kathryn Hunter, Andres Klein-Szanto, Bruce Ruggeri, The effects of the oral, pan-VEGF-R kinase inhibitor CEP-7055 and chemotherapy in orthotopic models of glioblastoma and colon carcinoma in mice. Molecular Cancer Therapeutics. ,vol. 5, pp. 1744- 1753 ,(2006) , 10.1158/1535-7163.MCT-05-0327
Robert Jaffe, Jocelyn Holash, Limin Hu, George D. Yancopoulos, Composition of a vegf antagonist and an anti-proliferative agent and its use for the treatment of cancer ,(2004)